Effectiveness of proton pump inhibitors in nonerosive reflux disease

Slides:

Advertisements

Similar presentations

Genetic testing for high-risk colon cancer patients1 William M. Grady Gastroenterology Volume 124, Issue 6, Pages (May 2003) DOI: /S (03)

Advertisements

Celiac Disease Genetics: Current Concepts and Practical Applications Ludvig M. Sollid, Benedicte A. Lie Clinical Gastroenterology and Hepatology Volume.

Small Intestinal Bacterial Overgrowth in Rosacea: Clinical Effectiveness of Its Eradication Andrea Parodi, Stefania Paolino, Alfredo Greco, Francesco.

Natural history of pruritus in primary biliary cirrhosis

Masatoshi Kudo Clinical Gastroenterology and Hepatology

Systematic Review of the Quality of Patient Information on the Internet Regarding Inflammatory Bowel Disease Treatments Morgan Langille, André Bernard,

Opened Proton Pump Inhibitor Capsules Reduce Time to Healing Compared With Intact Capsules for Marginal Ulceration Following Roux-en-Y Gastric Bypass

Effect of alosetron on bowel urgency and global symptoms in women with severe, diarrhea-predominant irritable bowel syndrome: Analysis of two controlled.

Conscious Awakenings Are Commonly Associated With Acid Reflux Events in Patients With Gastroesophageal Reflux Disease Choo Hean Poh, Larissa Allen, Anita.

Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole Gerald Holtmann*,

Mentore Ribolsi, Richard H

High Prevalence of Osteoporosis in Patients With Chronic Pancreatitis: A Systematic Review and Meta-analysis Sinead N. Duggan, Niamh D. Smyth, Anne Murphy,

Ashwin N. Ananthakrishnan, Millie D. Long, Christopher F

Noncardiac Chest Pain Clinical Gastroenterology and Hepatology

Millie D. Long, Bruce E. Sands

Double-Balloon Endoscopy

Efficacy of Proton Pump Inhibitor Drugs for Inducing Clinical and Histologic Remission in Patients With Symptomatic Esophageal Eosinophilia: A Systematic.

Michael F. Vaezi, David Katzka, Frank Zerbib

Biomarkers of Reflux Disease

Chad A. Morse, Stuart F. Quan, Mary Z

Prevalence of Irritable Bowel Syndrome–type Symptoms in Patients With Celiac Disease: A Meta-analysis Anita Sainsbury, David S. Sanders, Alexander C.

Benjamin C.Y. Wong, Yoshikazu Kinoshita

Patient-Reported Outcome Measures for Use in Clinical Trials and Clinical Practice in Inflammatory Bowel Diseases: A Systematic Review Marin J. de Jong,

Risks and Benefits of Infliximab for the Treatment of Crohn’s Disease

Small Intestinal Bacterial Overgrowth in Rosacea: Clinical Effectiveness of Its Eradication Andrea Parodi, Stefania Paolino, Alfredo Greco, Francesco.

Risk of Colorectal Cancer in Patients With Ulcerative Colitis: A Meta-analysis of Population-Based Cohort Studies Tine Jess, Christine Rungoe, Laurent.

Serhat Bor, Gul Kitapcioglu, Peter Dettmar, Tim Baxter

Management of Patients With Functional Heartburn

Mentore Ribolsi, Richard H

Issue Highlights Clinical Gastroenterology and Hepatology

Long-Term Outcomes of Nonalcoholic Fatty Liver Disease: From Nonalcoholic Steatohepatitis to Nonalcoholic Steatofibrosis Zobair M. Younossi Clinical.

Genetics of Colonic Polyposis

Maintenance of Heartburn Relief After Step-Down From Twice-Daily Proton Pump Inhibitor to Once-Daily Dexlansoprazole Modified Release Ronnie Fass, John.

Volume 133, Issue 6, Pages (December 2007)

Translating Improved Quality of Care Into an Improved Quality of Life for Patients With Inflammatory Bowel Disease Corey A. Siegel, John I. Allen, Gil.

Ikuo Hirano, Qing Zhang, John E. Pandolfino, Peter J. Kahrilas

Systematic Review of the Quality of Patient Information on the Internet Regarding Inflammatory Bowel Disease Treatments Morgan Langille, André Bernard,

Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease David A. Johnson, M.Brian Fennerty

Celiac Disease Patients Presenting With Anemia Have More Severe Disease Than Those Presenting With Diarrhea Hussein Abu Daya, Benjamin Lebwohl, Suzanne.

Patrick Hoversten, Fouad Otaki, David A. Katzka

Many Patients Continue Using Proton Pump Inhibitors After Negative Results From Tests for Reflux Disease Andrew J. Gawron, Jami Rothe, Angela J. Fought,

Severe Constipation Clinical Gastroenterology and Hepatology

Ronnie Fass, Stephen J. Sontag, Barry Traxler, Mark Sostek

Conscious Awakenings Are Commonly Associated With Acid Reflux Events in Patients With Gastroesophageal Reflux Disease Choo Hean Poh, Larissa Allen, Anita.

Time Trends of Gastroesophageal Reflux Disease: A Systematic Review

David H. Bruining, William J. Sandborn

Histologic Changes in Liver Tissue From Patients With Chronic Hepatitis B and Minimal Increases in Levels of Alanine Aminotransferase: A Meta-analysis.

Prednisolone and Budesonide for Short- and Long-Term Treatment of Microscopic Colitis: Systematic Review and Meta-analysis Michael J. Stewart, Cynthia.

Peter Bytzer Clinical Gastroenterology and Hepatology

Systematic Review: Patterns of Proton Pump Inhibitor Use and Adherence in Gastroesophageal Reflux Disease A. Pali S. Hungin, Catherine Hill, Michael.

Risk of Cerebrovascular Accidents and Ischemic Heart Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis Siddharth.

Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole Gerald Holtmann*,

The Utility of Intraluminal Impedance in Patients With Gastroesophageal Reflux Disease–Like Symptoms But Normal Endoscopy and 24-Hour pH Testing Michael.

Chronic Diarrhea Clinical Gastroenterology and Hepatology

Nicolas Williet, William J. Sandborn, Laurent Peyrin–Biroulet

Issue Highlights Clinical Gastroenterology and Hepatology

Volume 156, Issue 5, Pages (April 2019)

Effect of alosetron on bowel urgency and global symptoms in women with severe, diarrhea-predominant irritable bowel syndrome: Analysis of two controlled.

Incidence of Neoplasms in Patients Who Develop Sustained Leukopenia During or After Treatment With 6-Mercaptopurine for Inflammatory Bowel Disease William.

A 27-Year-Old Woman With Constipation: Diagnosis and Treatment

Resolution of Decompensated Cirrhosis From Wilson’s Disease With Zinc Monotherapy: A Potential Therapeutic Option? Vanessa D. Lee, Patrick G. Northup,

Coagulation in Liver Disease: A Guide for the Clinician

Lauren B. Gerson, Peter J. Kahrilas, Ronnie Fass

Clinical application of polymerase chain reaction to diagnose Clostridium difficile in hospitalized patients with diarrhea Michael S. Morelli, Susan.

Risk of Pancreatitis in Patients With Celiac Disease: Is Autoimmune Pancreatitis a Biologically Plausible Mechanism? John S. Leeds, David S. Sanders

Masatoshi Kudo Clinical Gastroenterology and Hepatology

Natural history of pruritus in primary biliary cirrhosis

Scott K. Fung, Anna S.F. Lok Clinical Gastroenterology and Hepatology

Medical Therapy for Refractory Pediatric Crohn’s Disease

Choosing Wisely and the Perceived Drivers of Endoscopy Use

Presentation transcript:

Effectiveness of proton pump inhibitors in nonerosive reflux disease Bonnie B. Dean, Anacleto D. Gano, Kevin Knight, Joshua J. Ofman, Ronnie Fass Clinical Gastroenterology and Hepatology Volume 2, Issue 8, Pages 656-664 (August 2004) DOI: 10.1016/S1542-3565(04)00288-5

Figure 1 Flowchart of the systematic review for NERD and symptomatic GERD. Clinical Gastroenterology and Hepatology 2004 2, 656-664DOI: (10.1016/S1542-3565(04)00288-5)

Figure 2 Treatment comparison with placebo for group 1 (endoscopy negative) patients: pooled difference (treatment − placebo) in proportion with heartburn resolution by time. ▴, Sufficient; ■, complete. Clinical Gastroenterology and Hepatology 2004 2, 656-664DOI: (10.1016/S1542-3565(04)00288-5)

Figure 3 Treatment comparison with placebo for group 2 (negative endoscopy and erythema and friability) patients: pooled difference (treatment − placebo) in proportion with heartburn resolution by time. ▴, Sufficient; ■, complete. Clinical Gastroenterology and Hepatology 2004 2, 656-664DOI: (10.1016/S1542-3565(04)00288-5)

Figure 4 Treatment comparison with placebo for all studies (group 3): pooled difference (treatment − placebo) in proportion with heartburn resolution by time. ▴, Sufficient; ■, complete. Clinical Gastroenterology and Hepatology 2004 2, 656-664DOI: (10.1016/S1542-3565(04)00288-5)